Stay updated on Advanced Cancers Nivolumab Immuno-therapy Clinical Trial
Sign up to get notified when there's something new on the Advanced Cancers Nivolumab Immuno-therapy Clinical Trial page.

Latest updates to the Advanced Cancers Nivolumab Immuno-therapy Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check21 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference2%
- Check28 days agoNo Change Detected
- Check49 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check64 days agoChange DetectedThe page has been updated to include a new revision number (v2.15.0) and the EudraCT number for the study, while significant details about the study's purpose and eligibility criteria have been removed.SummaryDifference6%
- Check71 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check78 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
Stay in the know with updates to Advanced Cancers Nivolumab Immuno-therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Advanced Cancers Nivolumab Immuno-therapy Clinical Trial page.